Project Grant F32AI183749
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $461,375 to Yale University to systematically identify interactions between Lyme disease bacteria (Borrelia burgdorferi) and the extracellular, secreted, and transmembrane proteins of the tick vector Ixodes scapularis. The goal is to develop a better understanding of the critical pathogen-vector...
- This $625,276 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is focused on understanding the mechanisms used by the bacterial pathogen Coxiella burnetii to manipulate host cells and cause the human disease Q-fever. The project leverages newly developed genetic tools to investigate how specific Coxiella effector proteins interfere with host immune responses, promote the formation...
- This Project Grant award of $427,604 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the molecular mechanisms of conoid extrusion in the pathogen Toxoplasma gondii. The goal is to reconstitute the core elements of the parasite's apical complex, including actin, myosin, and a formin, in vitro to gain a mechanistic understanding of how the conoid structure is extruded...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $3,315,179 to Tufts University School of Medicine to conduct research on the microbial determinants of excessive inflammation and severe Lyme disease. The researchers will leverage a unique collection of clinical samples and isogenic Borrelia burgdorferi strains to systematically delineate the immunogenic...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $520,128 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) federal grant program to the University of Texas Medical Branch at Galveston. The project, titled "Ehrlichia Modulation of RNA Splicing to Influence Kirrel1-Regulated Hippo Signaling", aims to investigate how the bacterial pathogen Ehrlichia chaffeensis manipulates host cell RNA splicing factors to promote infection and...
- This $2,494,866 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to characterize innate immune signaling pathways in the tick Ixodes scapularis. The project aims to improve understanding of immune signaling in ticks, which are vectors of Lyme disease and other emerging infectious diseases. The research will combine cell culture-based methods with in vivo assays...
- The University of Georgia Research Foundation was awarded a $540,193 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The 12-month award, effective August 22, 2023, supports research to investigate the role of calcium-binding proteins and other secretory pathway components in the exocytosis of organelles critical for the invasion and egress of the malaria parasite Plasmodium falciparum...
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a 2-year, $431,750 Project Grant to the University of California, Irvine to develop an "Immunological Toolbox for Genus Peromyscus, Infection Tolerant Reservoirs of Zoonotic Agents." The project aims to address the limited availability of research tools for in-depth study of the immunology and host responses of the...
- This Project Grant award, valued at $148,500, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to investigate the role of calcium ions (Ca2+) in the assembly of the exosporium, an outer protective layer of Bacillus anthracis spores that is critical for spore survival and infectivity. The research aims to characterize the molecular mechanisms by which the...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $431,143 Project Grant to Tufts University School of Medicine under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of this 3-year grant, beginning January 23, 2025, is to develop methods for continuous in vitro propagation of the parasite Babesia microti, which is responsible for increasing rates of human babesiosis in the Northeastern U.S. Specifically, the grant will fund research to...
ANAPLASMA PHAGOCYTOPHILUM EXPLOITATION OF REGULATED EXOCYTOSIS. - SUMMARY REGULATED EXOCYTOSIS IS A CONSERVED EUKARYOTIC PROCESS THAT IS ESSENTIAL FOR NUMEROUS CELLULAR FUNCTIONS, MAKING IT A PRIME TARGET FOR EXPLOITATION BY BOTH INFECTIOUS AND NON-INFECTIOUS DISEASES. INDEED, VARIOUS MALIGNANCIES, VIRUSES, BACTERIA, AND PROTOZOA COMMANDEER THIS PATHWAY TO PROMOTE DISEASE PROGRESSION. NUMEROUS STUDIES HAVE INTERROGATED THE MOLECULAR PLAYERS OF REGULATED EXOCYTOSIS THAT ARE MODULATED IN CANCER FORMATION, INCLUDING THE CONSERVED SECOND MESSENGERS, CALCIUM (CA2+) AND SPHINGOSINE-1-PHOSPHATE (S1P). HOWEVER, FAR LESS IS KNOWN ABOUT THE MECHANISMS THAT INTRACELLULAR BACTERIAL PATHOGENS EMPLOY TO EXPLOIT THIS PROCESS. HUMAN GRANULOCYTIC ANAPLASMOSIS IS AN EMERGENT DISEASE CAUSED BY THE OBLIGATE INTRACELLULAR VACUOLAR-ADAPTED BACTERIUM, ANAPLASMA PHAGOCYTOPHILUM (AP). AP IS A TICK-TRANSMITTED PATHOGEN THAT EXHIBITS AN UNUSUAL TROPISM FOR NEUTROPHILS. A PRIMARY FUNCTION OF NEUTROPHILS IS TO DESTROY MICROORGANISMS THROUGH DEGRANULATION, A FORM OF REGULATED EXOCYTOSIS. INTRIGUINGLY, BOTH AP-INFECTED NEUTROPHILS AND TICKS EXHIBIT PROLONGED DEGRANULATION AND INCREASED EXOCYTOSIS, RESPECTIVELY. WE RECENTLY PUBLISHED THAT THE AP- CONTAINING VACUOLE (APV) RESEMBLES A HOST MULTIVESICULAR BODY (AN ORGANELLE THAT UNDERGOES REGULATED EXOCYTOSIS) AND THAT LATE-STAGE APVS MOBILIZE TO AND FUSE WITH THE PLASMA MEMBRANE TO RELEASE AP INTO EXTRACELLULAR MILIEU FOR REINFECTION. OUR PRELIMINARY RESULTS INDICATE THAT INTRACELLULAR CA2+ CONCENTRATION ([CA2+]I), SPHINGOSINE KINASE 1 (SK1 [PRODUCES S1P]), AND S1P ARE INCREASED LATE IN AP INFECTION AND THAT INHIBITION OF AP PROTEIN SYNTHESIS PREVENTS THESE PHENOMENA AS WELL AS APV EXOCYTOSIS. THESE DATA SUGGEST THAT AP MANIPULATES REGULATED EXOCYTOSIS FOR EGRESS. WE ALSO UNCOVERED A POTENTIAL MECHANISTIC ROLE FOR THE AP EFFECTOR, P130, IN THIS PROCESS. P130 IS UPREGULATED DURING LATE AP INFECTION AND LOCALIZES TO THE CYTOSOLIC FACE OF THE APV MEMBRANE. WE DISCOVERED THAT P130 INTERACTS WITH HOST CALCIUM AND INTEGRIN-BINDING PROTEIN 1 (CIB1), WHICH, TO DATE, HAS BEEN INDIRECTLY IMPLICATED IN REGULATED EXOCYTOSIS. CIB1 ALSO LOCALIZES WITH P130 ON EXOCYTOSING APVS, FURTHER SUPPORTING ITS ROLE IN AP DISSEMINATION. IN AIM 1, WE WILL INTERROGATE THE RELEVANCE OF [CA2+]I AND S1P TO APV EXOCYTOSIS AND INFECTIOUS PROGENY RELEASE USING IN VITRO AND IN VIVO APPROACHES. IN AIM 2, WE WILL IDENTIFY THE P130 DOMAINS NECESSARY FOR ITS INTERACTION WITH CIB1 AND ITS PROMOTION OF APV EXOCYTOSIS AS WELL AS DETERMINE THE RELEVANCE OF CIB1 TO APV EXOCYTOSIS IN VITRO AND IN VIVO. THIS WORK WILL ADVANCE OUR FUNDAMENTAL UNDERSTANDING OF THE MECHANISMS THAT INTRACELLULAR BACTERIAL PATHOGENS UTILIZE TO FACILITATE THEIR RELEASE AND POTENTIALLY DEFINE NOVEL ROLES FOR CIB1 IN HOST CELL BIOLOGY AND INFECTIOUS DISEASE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.2k | 8/4/25 | ||
| Not listed | $73.8k | 5/16/25 | ||
| Not listed | $73.8k | 5/16/25 | ||
| Not listed | $0 | 7/8/24 | ||
| Not listed | $0 | 7/8/24 |